Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
172.10
-2.27 (-1.30%)
May 8, 2026, 3:30 PM IST
Nath Bio-Genes (India) Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 759.95 | 888.99 | 774.1 | 379.95 | 41.81 |
Cash & Short-Term Investments | 759.95 | 888.99 | 774.1 | 379.95 | 41.81 |
Cash Growth | -14.52% | 14.84% | 103.73% | 808.85% | -85.69% |
Accounts Receivable | 854.15 | 889.02 | 943.09 | 973.14 | 855.48 |
Other Receivables | 9.79 | 72.71 | 64.08 | 63.68 | 71.79 |
Receivables | 863.94 | 961.72 | 1,007 | 1,037 | 927.27 |
Inventory | 4,505 | 3,380 | 2,303 | 2,078 | 2,203 |
Prepaid Expenses | - | 4.29 | 2.9 | 3.6 | 3.48 |
Other Current Assets | 1,659 | 1,665 | 1,629 | 1,699 | 1,502 |
Total Current Assets | 7,789 | 6,900 | 5,717 | 5,198 | 4,678 |
Property, Plant & Equipment | 2,438 | 2,432 | 2,406 | 2,340 | 2,329 |
Long-Term Investments | 59.02 | 57.82 | 60.46 | 50.48 | 50.48 |
Other Intangible Assets | 55.86 | 71.82 | 88.12 | 104.17 | 120.26 |
Other Long-Term Assets | 632.5 | 442.16 | 421.59 | 235.4 | 217.86 |
Total Assets | 10,974 | 10,262 | 8,802 | 7,928 | 7,395 |
Accounts Payable | 1,311 | 794.84 | 432.96 | 277.36 | 427.82 |
Accrued Expenses | - | 139.11 | 104.31 | 97.99 | 117 |
Short-Term Debt | 1,212 | 48.78 | 49.12 | 10.33 | 18.84 |
Current Portion of Long-Term Debt | - | 1,046 | 1,006 | 1,038 | 904.1 |
Current Income Taxes Payable | 14.62 | 3.9 | 9.47 | 2.81 | 8.87 |
Current Unearned Revenue | - | 1,142 | 645.95 | 513.23 | 238.37 |
Other Current Liabilities | 1,409 | 478.42 | 376.96 | 224.87 | 227.91 |
Total Current Liabilities | 3,947 | 3,653 | 2,624 | 2,164 | 1,943 |
Long-Term Debt | 173.22 | 129.76 | 48.65 | 4.03 | 6.65 |
Pension & Post-Retirement Benefits | - | 35.43 | 30 | 22.35 | 18.39 |
Other Long-Term Liabilities | 49.47 | - | -0 | 5.52 | 7.71 |
Total Liabilities | 4,170 | 3,818 | 2,703 | 2,196 | 1,976 |
Common Stock | 190.04 | 190.04 | 190.04 | 190.04 | 190.04 |
Additional Paid-In Capital | - | 1,335 | 1,335 | 1,335 | 1,335 |
Retained Earnings | - | 4,792 | 4,444 | 4,086 | 3,774 |
Comprehensive Income & Other | 6,615 | 126.4 | 129.7 | 120.43 | 120.22 |
Total Common Equity | 6,805 | 6,444 | 6,099 | 5,732 | 5,419 |
Minority Interest | - | - | - | - | -0.05 |
Shareholders' Equity | 6,805 | 6,444 | 6,099 | 5,732 | 5,419 |
Total Liabilities & Equity | 10,974 | 10,262 | 8,802 | 7,928 | 7,395 |
Total Debt | 1,385 | 1,225 | 1,103 | 1,052 | 929.59 |
Net Cash (Debt) | -625.06 | -336.01 | -329.36 | -672.17 | -887.78 |
Net Cash Per Share | -31.50 | -17.68 | -17.33 | -35.37 | -46.72 |
Filing Date Shares Outstanding | 22.36 | 19 | 19 | 19 | 19 |
Total Common Shares Outstanding | 22.36 | 19 | 19 | 19 | 19 |
Working Capital | 3,842 | 3,247 | 3,092 | 3,034 | 2,735 |
Book Value Per Share | 304.35 | 339.08 | 320.94 | 301.61 | 285.16 |
Tangible Book Value | 6,749 | 6,372 | 6,011 | 5,628 | 5,299 |
Tangible Book Value Per Share | 301.86 | 335.30 | 316.31 | 296.12 | 278.84 |
Land | - | 2,225 | 2,221 | 2,221 | 2,221 |
Buildings | - | 60.52 | 48.67 | 33.78 | 31.28 |
Machinery | - | 342.95 | 311.9 | 280.98 | 260.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.